Mario Raviglione
World Health Organization official
Why Is Mario Raviglione Influential?
(Suggest an Edit or Addition)According to Wikipedia, Mario C. Raviglione has been professor at the University of Milan, Italy since March 2018. He directs the activities focused on global health and aiming at pursuing didactic and research in this field as part of the new Multidisciplinary Research in Health Science Centre . Part of his activities are devoted to teaching global health principles to undergraduate medical students, making the University of Milan the first in Italy, and one of the pioneers world-wide, introducing global health as a module among the required curricular courses. At the same university, Raviglione is now coordinating the first international Master Course in Global Health in Italy and one of th very few online worldwide . In 2019 and 2020, he was also Professeur Titulaire at the Global Studies Institute , Université de Genève, Suisse . Through the GSI, he has worked within the context of the Institute of Global Health . Previously, between 2003 and 2017, he was director of the Global Tuberculosis Programme at the World Health Organization . He graduated in medicine from the University of Turin in 1980 and then trained in internal medicine and Infectious Diseases at Cabrini Medical Center in New York City and at Beth Israel Medical Center in Boston where he was a Harvard University Clinical Fellow in Medicine and specialised in AIDS. Back in Europe, Raviglione joined WHO in 1991 as a Junior Professional Officer, and spent a few years working on TB and AIDS, TB epidemiology in Europe, and anti-TB drug resistance surveillance and response. In the mid-1990s, he set up both the WHO global drug resistance surveillance project and the WHO global TB surveillance and monitoring systems . Among his major achievements are the contributions to the development of the WHO's DOTS Strategy in 1995, and the direction of the development of both the Stop TB Strategy in 2006 and the End TB Strategy in 2014 . During his years at WHO he worked with, and visited, more than 50 countries supporting their TB care, prevention, control and research activities. His research work has resulted in over 350 scientific articles and chapters on the topics of infectious diseases, HIV/AIDS, TB, and global health, including the TB chapters in the last eight editions of Harrison's Principles of Internal Medicine. He is editor of the 3rd and 4th edition of "Tuberculosis - A comprehensive international approach", a multi-author book, and associate editor of other books on public health, infectious diseases and tuberculosis. He directed the team that developed the book “Systematic screening for active tuberculosis – Principles and recommendations”, awarded by the British Medical Association as "Highly Commended Book" for Public Health in 2014 . He is among the top 10 most cited authors in the TB field. His h-index is 117 and 94 and his work has been cited over 63000 times . He is also among the top 25 Italian epidemiological scientists and the top 100 Italian scientists in general . As an expert in TB, he has worked as a teacher or visiting professor at Johns Hopkins University, University of Geneva, University of Modena and Reggio Emilia, and University of Pavia. He has been visiting professor at the University of Brescia and has recently lectured at major universities including Harvard, McGill and Sydney. He participates in a variety of board of directors, scientific and advisory committees, including those of the TB Alliance, Doctors with Africa CUAMM, BE Health Association, International Health Commission of the Missionary Sisters of the Sacred Heart - Cabrini Ministries ,Fondazione 3Bi. and the McGill Global Health Programs International Advisory Board . In 2017-2018 and in 2023 he was member of the Lancet Commission on TB . During 2015-2017 he conceived and co-organised, with WHO and the Russian Federation Ministry of Health, the first Global WHO Ministerial Conference on TB in the Sustainable Development Era, held in Moscow on 16–17 November 2017, and his team worked towards ensuring that TB is raised in the international political agenda through the United Nations General Assembly high-level meeting on TB that was held in 2018 . As main Editor, he conceived and coordinated with other global health authorities the publication of a landmark book "Global Health Essentials" part of the Springer series devoted to the UN Sustainable Development Goals . This practical manual is a comprehensive book written by an esteemed international panel of over 150 experts from 70 institutions across 30 countries, and provides a succinct yet thorough exploration of key global health challenges, issues, and solutions.
Mario Raviglione's Published Works
Published Works
- The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. (2003) (2942)
- Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. (1999) (2905)
- Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. (1995) (1789)
- Zoonotic tuberculosis due to Mycobacterium bovis in developing countries. (1998) (937)
- Global tuberculosis incidence and mortality during 1990-2000. (1994) (888)
- Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. (1998) (883)
- Drivers of tuberculosis epidemics: the role of risk factors and social determinants. (2009) (881)
- Tuberculosis control and elimination 2010–50: cure, care, and social development (2010) (785)
- WHO's new End TB Strategy (2015) (775)
- ANTI-TUBERCULOSIS DRUG RESISTANCE IN THE WORLD (2000) (727)
- Global trends in resistance to antituberculosis drugs. (2001) (661)
- Towards tuberculosis elimination: an action framework for low-incidence countries (2015) (656)
- International standards for tuberculosis care. (2006) (594)
- Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. (2000) (564)
- Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. (2005) (559)
- Latent Mycobacterium tuberculosis infection. (2015) (490)
- Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries (2015) (477)
- WHO's new Stop TB Strategy (2006) (436)
- Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review (2014) (418)
- Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance (2009) (401)
- The Global Plan to Stop TB, 2006-2015. (2006) (391)
- XDR tuberculosis--implications for global public health. (2007) (379)
- Trends in tuberculosis incidence and their determinants in 134 countries. (2009) (364)
- Global epidemiology of tuberculosis: prospects for control. (2008) (359)
- Drug-Resistant Tuberculosis: Review of the Worldwide Situation and the WHO/IUATLD Global Surveillance Project (1997) (345)
- HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention. (1992) (340)
- Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis (2002) (332)
- Scaling up interventions to achieve global tuberculosis control: progress and new developments (2012) (331)
- Prospects for tuberculosis elimination. (2013) (328)
- HIV-associated tuberculosis in developing countries: clinical features, diagnosis, and treatment. (1992) (305)
- The WHO policy package to combat antimicrobial resistance. (2011) (290)
- Secular trends of tuberculosis in western Europe. (1993) (285)
- The TB epidemic from 1992 to 2002. (2003) (279)
- Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis (2006) (276)
- Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Antituberculosis Drugs (2008) (275)
- Global burden of tuberculosis (1999) (270)
- Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010. (2012) (268)
- Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru (2002) (267)
- Private practitioners and public health: weak links in tuberculosis control (2001) (265)
- The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era. (2018) (263)
- Drug-resistant tuberculosis: time for visionary political leadership. (2013) (263)
- Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF (2012) (257)
- Tuberculosis control in the era of HIV (2005) (257)
- Guidelines for surveillance of drug resistance in tuberculosis. WHO Geneva/IUATLD Paris. International Union Against Tuberculosis and Lung Disease. (1998) (248)
- Global tuberculosis control: lessons learnt and future prospects (2012) (226)
- European Union Standards for Tuberculosis Care (2012) (219)
- Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. (2001) (218)
- Clinical and operational value of the extensively drug-resistant tuberculosis definition (2007) (216)
- Zoonotic tuberculosis in human beings caused by Mycobacterium bovis-a call for action. (2017) (216)
- Determinants of drug-resistant tuberculosis: analysis of 11 countries. (2001) (215)
- Building a tuberculosis-free world: The Lancet Commission on tuberculosis (2019) (214)
- Tuberculosis 2015: Burden, Challenges and Strategy for Control and Elimination (2016) (212)
- Risk Factors for Tuberculosis in HIV-lnfected Persons: A Prospective Cohort Study (1995) (208)
- 125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is “science” enough to tackle the epidemic? (2007) (200)
- Assessment of worldwide tuberculosis control (1997) (191)
- Standardized tuberculosis treatment outcome monitoring in Europe (1998) (191)
- Surveillance of tuberculosis in Europe. Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting on tuberculosis cases. (1996) (190)
- Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA). (1995) (186)
- MDR tuberculosis--critical steps for prevention and control. (2010) (186)
- Tuberculosis and HIV: current status in Africa. (1997) (181)
- Global Epidemiology of Tuberculosis (2018) (179)
- Multidrug-resistant Tuberculosis Management in Resource-limited Settings (2006) (179)
- Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs. (2012) (172)
- The global fight against HIV/AIDS, tuberculosis, and malaria: current status and future perspectives. (2009) (171)
- Drug-resistant tuberculosis: laboratory issues. World Health Organization recommendations. (1994) (170)
- Hospital-Acquired Infections in Critically Ill Patients With COVID-19 (2021) (164)
- New drugs for the treatment of tuberculosis: needs, challenges, promise, and prospects for the future. (2012) (160)
- Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration. (2006) (160)
- Tuberculosis: Epidemiology and Control (2014) (156)
- Tuberculosis elimination: theory and practice in Europe (2014) (153)
- Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action (2010) (137)
- Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project (2016) (136)
- New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmes (2010) (135)
- Buruli ulcer. Mycobacterium ulcerans infection. (2002) (135)
- Responding to Market Failures in Tuberculosis Control (2001) (135)
- Extrapulmonary pneumocystosis: the first 50 cases. (1990) (133)
- Infections associated with Hickman catheters in patients with acquired immunodeficiency syndrome. (1989) (132)
- Drug resistance among failure and relapse cases of tuberculosis: is the standard re-treatment regimen adequate? (2003) (130)
- Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US. (2000) (130)
- Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998. (2002) (129)
- The WHO's new End TB Strategy in the post-2015 era of the Sustainable Development Goals (2016) (128)
- Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis: epidemiology and control (2007) (128)
- Increasing transparency in partnerships for health – introducing the Green Light Committee (2002) (125)
- Tuberculosis control in Europe and international migration. (1994) (125)
- Draft global strategy and targets for tuberculosis prevention , care and control after 2015 Report by the Secretariat (2013) (123)
- Beyond UHC: Monitoring Health and Social Protection Coverage in the Context of Tuberculosis Care and Prevention (2014) (123)
- Preventive chemotherapy for HIV‐associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre (1995) (122)
- Tuberculosis management in Europe. Task Force of the European Respiratory Society (ERS), the World Health Organisation (WHO) and the International Union against Tuberculosis and Lung Disease (IUATLD) Europe Region. (1999) (121)
- Targets for global tuberculosis control. (2006) (120)
- Tuberculosis and noncommunicable diseases: neglected links and missed opportunities (2010) (120)
- The global tuberculosis situation. Progress and problems in the 20th century, prospects for the 21st century. (2002) (120)
- XDR-TB: entering the post-antibiotic era? (2006) (120)
- Systematic screening for active tuberculosis: rationale, definitions and key considerations. (2013) (119)
- Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions (2010) (116)
- Extensively drug-resistant tuberculosis, Italy and Germany. (2007) (116)
- Prevention, diagnosis, and treatment of tuberculosis in children and mothers: evidence for action for maternal, neonatal, and child health services. (2012) (112)
- Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital (2020) (112)
- Twenty Years of Global Surveillance of Antituberculosis-Drug Resistance. (2016) (111)
- Scale up: meeting targets in global tuberculosis control (2004) (110)
- Global burden and epidemiology of tuberculosis. (2009) (109)
- Multidrug-resistant tuberculosis around the world: what progress has been made? (2014) (109)
- Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice. (1993) (107)
- Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing. (1997) (105)
- Tuberculosis trends in eastern Europe and the former USSR. (1994) (101)
- Standardization of antituberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group. (2000) (101)
- Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study (2018) (99)
- Progress in global tuberculosis control 1995-1996, with emphasis on 22 high-incidence countries. Global Monitoring and Surveillance Project. (1999) (96)
- Impact of the HIV epidemic on the spread of other diseases: the case of tuberculosis. (2000) (94)
- Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease. (1997) (94)
- Stigma at the time of the COVID-19 pandemic (2020) (93)
- The impact of social protection and poverty elimination on global tuberculosis incidence: a statistical modelling analysis of Sustainable Development Goal 1 (2018) (92)
- Latent Mycobacterium tuberculosis Infection. (2015) (90)
- Rational 'DOTS plus' for the control of MDR-TB. (1999) (90)
- Tuberculosis control in prisons : a manual for programme managers (2000) (90)
- Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospital (1990) (87)
- Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance data. (2013) (86)
- Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality. (2011) (83)
- Involving private practitioners in tuberculosis control: issues, interventions, and emerging policy framework (2001) (81)
- Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy. (2002) (80)
- Global epidemiology of tuberculosis. (2015) (78)
- Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives (2019) (78)
- The Burden of Drug‐Resistant Tuberculosis and Mechanisms for Its Control (2001) (78)
- The new Stop TB Strategy and the Global Plan to Stop TB, 2006-2015. (2007) (77)
- Epidemic and pandemic viral infections: impact on tuberculosis and the lung (2020) (77)
- The health workforce crisis in TB control: a report from high-burden countries (2005) (77)
- Seroprevalence of human immunodeficiency virus type 1 infection in Zambian children with tuberculosis (1993) (75)
- Resources Required for Global Tuberculosis Control (2002) (74)
- Cutaneous hypersensitivity reactions due to thiacetazone in the treatment of tuberculosis in Zambian children infected with HIV-I. (1993) (72)
- Community contribution to tuberculosis care in countries with high tuberculosis prevalence: past, present and future. (1999) (70)
- Planning to improve global health: the next decade of tuberculosis control. (2007) (69)
- Global tuberculosis targets and milestones set for 2016–2035: definition and rationale (2018) (68)
- How human immunodeficiency virus voluntary testing can contribute to tuberculosis control. (2003) (67)
- Global Tuberculosis Control: Toward the 2015 Targets and Beyond (2015) (66)
- Evidence of SARS-CoV-2 RNA in an Oropharyngeal Swab Specimen, Milan, Italy, Early December 2019 (2020) (64)
- Stopping tuberculosis in the 21st century: Goals and strategies (2010) (62)
- Tuberculosis in HIV‐infected persons in the context of wide availability of highly active antiretroviral therapy (2004) (62)
- Directly observed therapy and treatment adherence (2000) (61)
- Translational Research for Tuberculosis Elimination: Priorities, Challenges, and Actions (2016) (61)
- Global epidemiology of tuberculosis. (2005) (61)
- Dynamics and control of the global tuberculosis epidemic (2000) (61)
- Global Epidemiology of Tuberculosis (2013) (61)
- Digital health for the End TB Strategy: developing priority products and making them work (2016) (60)
- Human immunodeficiency virus type-1 infection in Zambian children with tuberculosis: changing seroprevalence and evaluation of a thioacetazone-free regimen. (1994) (60)
- Global Epidemiology of Tuberculosis: Morbidity and Mortality of a Worldwide Epidemic (1996) (58)
- CURRENT CONCEPTS Tuberculosis (2013) (57)
- The World Health Organization standards for tuberculosis care and management (2018) (57)
- Epidemiology of Antituberculosis Drug Resistance in Saudi Arabia: Findings of the First National Survey (2013) (57)
- Tuberculosis: the role of risk factors and social determinants. (2010) (57)
- Harmonisation of TB control in the WHO European region: the history of the Wolfheze Workshops (2010) (56)
- TB / HIV: a clinical manual. 2nd ed. (2004) (54)
- Systematic screening for active tuberculosis: rationale, definitions and key considerations [State of the art series. Active case finding/screening. Number 1 in the series]. (2013) (53)
- WHO and the future of disease control programmes (2013) (53)
- Domestic and donor financing for tuberculosis care and control in low-income and middle-income countries: an analysis of trends, 2002-11, and requirements to meet 2015 targets. (2013) (52)
- The "vertical-horizontal" debates: time for the pendulum to rest (in peace)? (2007) (51)
- HighStaphylococcus aureus nasal carriage rate in patients with acquired immunodeficiency syndrome or AIDS-related complex (1990) (51)
- Tuberculosis and HIV in people who inject drugs: evidence for action for tuberculosis, HIV, prison and harm reduction services (2012) (50)
- Improving the TB case management: the International Standards for Tuberculosis care (2006) (49)
- Reichman and Hershfield's Tuberculosis: A Comprehensive, International Approach (2006) (48)
- Patients with previously treated tuberculosis no longer neglected. (2007) (47)
- Anti-tuberculosis Drug Resistance in the World: Report no. 2: Prevalence and Trends (2000) (47)
- Tuberculosis elimination: dream or reality? The case of Cyprus (2014) (47)
- TB: a clinical manual for South East Asia. (1997) (43)
- Tuberculosis care in community care organizations in sub-Saharan Africa: practice and potential. (1997) (43)
- The research agenda for improving health policy, systems performance, and service delivery for tuberculosis control: a WHO perspective. (2002) (43)
- High Staphylococcus aureus nasal carriage rate in patients with acquired immunodeficiency syndrome or AIDS-related complex. (1990) (42)
- Tuberculosis as a major global health problem in the 21st century: a WHO perspective. (2004) (42)
- Epidemiology of tuberculosis in the world (1997) (41)
- The COVID-19 pandemic preparedness ... or lack thereof: from China to Italy. (2020) (40)
- Surveillance of tuberculosis in Europe. (1996) (40)
- Costs and benefits of improving tuberculosis control: the case of Thailand. (1997) (39)
- Supervised preventive therapy for latent tuberculosis infection in illegal immigrants in Italy. (2000) (39)
- Numbers needed to treat to prevent tuberculosis (2015) (39)
- Preventive therapy of tuberculosis with rifapentine in immunocompetent and nude mice. (1994) (38)
- Towards the development of EU/EEA Standards for Tuberculosis Care (ESTC) (2011) (37)
- Public health. Responding to market failures in tuberculosis control. (2001) (37)
- Mandatory tuberculosis case notification in high tuberculosis-incidence countries: policy and practice (2016) (36)
- Fatal toxic epidermal necrolysis during prophylaxis with pyrimethamine and sulfadoxine in a human immunodeficiency virus-infected person. (1988) (36)
- Tuberculosis: still a social disease. (2011) (36)
- Tuberculosis control in the Caucasus: successes and constraints in DOTS implementation. (1999) (36)
- Ensuring rational introduction and responsible use of new TB tools: outcome of an ERS multisector consultation (2014) (35)
- Experience establishing tuberculosis laboratory capacity in a developing country setting. (2010) (35)
- Once-weekly rifapentine-containing regimens for treatment of tuberculosis in mice. (1998) (34)
- Drug resistant tuberculosis among the homeless in New York City. (1990) (34)
- Validation of the surveillance system for new cases of tuberculosis in a province of northern Italy. Varese Tuberculosis Study Group. (1995) (34)
- Pneumocystis carinii infection of the thyroid in a hypothyroid patient with AIDS: diagnosis by fine needle aspiration biopsy. (1991) (33)
- How human immunodeficiency virus voluntary testing can contribute to tuberculosis control. (2002) (33)
- The impact of COVID-19 and the restoration of tuberculosis services in the Western Pacific Region (2020) (33)
- Scaling-up treatment for HIV/AIDS: lessons learned from multidrug-resistant tuberculosis (2004) (33)
- Use of Digital Technology to Enhance Tuberculosis Control: Scoping Review (2019) (32)
- WHO's End TB Strategy: From stopping to ending the global TB epidemic. (2015) (31)
- Managing tuberculosis in people who use and inject illicit drugs. (2013) (30)
- Target regimen profiles for treatment of tuberculosis: a WHO document (2017) (30)
- Facing extensively drug-resistant tuberculosis--a hope and a challenge. (2008) (29)
- Update on the global epidemiology of tuberculosis. (1996) (29)
- Covid-19 in Latin America (2020) (29)
- What Research Is Needed to Stop TB? Introducing the TB Research Movement (2011) (28)
- Tuberculosis deaths in countries with high HIV prevalence: what is their use as an indicator in tuberculosis programme monitoring and epidemiological surveillance? (2005) (28)
- Recommendations of a Working Group of the World Health Organisation (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting by cohort analysis of treatment outcome in tuberculosis patients (1998) (28)
- Setting new targets in the fight against tuberculosis (2013) (28)
- Tuberculosis and poverty: what is being done. (2011) (28)
- Tuberculosis and air travel: WHO guidance in the era of drug-resistant TB. (2007) (28)
- Helicobacter pylori infection in patients with acquired immune deficiency syndrome. (1990) (27)
- Multidrug-resistant tuberculosis in Eastern Europe: still on the increase? (2012) (27)
- DOTS expansion: will we reach the 2005 targets? (2004) (26)
- Treatment of tuberculosis (2003) (26)
- Build back stronger universal health coverage systems after the COVID-19 pandemic: the need for better governance and linkage with universal social protection (2020) (26)
- Celebrating TB day at the time of COVID-19 (2020) (26)
- Erratum: Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice (American Journal of Respiratory and Critical Care Medicine (1993) 148 (1541-1546)) (1994) (25)
- Extrapulmonary Pneumocystis infection. (1989) (25)
- Preventing and managing antimicrobial resistance: imperative for chest physicians (2011) (24)
- Modernizing Surveillance of Antituberculosis Drug Resistance: From Special Surveys to Routine Testing (2011) (24)
- Tuberculosis control, and the where and why of artificial intelligence (2017) (24)
- Challenges and Controversies in Defining Totally Drug-Resistant Tuberculosis (2012) (24)
- Limitations on human rights: are they justifiable to reduce the burden of TB in the era of MDR- and XDR-TB? (2008) (23)
- Clinical Features and Management of Severe Dermatological Reactions to Drugs (1990) (23)
- Brain drain, brain exchange and brain circulation: the case of Italy viewed from a global perspective (2012) (23)
- WHO policies for tuberculosis control (2004) (23)
- Tuberculosis makes it onto the international political agenda for health…finally. (2018) (22)
- Tuberculosis : the essentials (2010) (22)
- Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)? (2001) (22)
- Splenectomy in patients with AIDS (1989) (22)
- Implementing the Global Plan to Stop TB, 2011–2015 – Optimizing Allocations and the Global Fund’s Contribution: A Scenario Projections Study (2012) (21)
- Ending infectious diseases in the era of the Sustainable Development Goals (2017) (21)
- Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. (2000) (21)
- A sustainable agenda for tuberculosis control and research (2012) (21)
- Active case-finding for TB in the community: time to act (2010) (21)
- Cost-comparison of different management policies for tuberculosis patients in Italy. AIPO TB Study Group. (1999) (21)
- Cost effectiveness analysis of tuberculosis control policies (in Invanovo Oblast, Russian Federation) (1998) (20)
- Expanding culture and drug susceptibility testing capacity in tuberculosis diagnostic services: the new challenge. (2007) (19)
- The role of eHealth and mHealth in tuberculosis and tobacco control: a WHO/ERS consultation (2015) (19)
- Cameroon's multidrug-resistant tuberculosis treatment programme jeopardised by cross-border migration (2016) (19)
- A roadmap for zoonotic tuberculosis: a One Health approach to ending tuberculosis. (2018) (19)
- Performance-related allowances within the Malawi National Tuberculosis Control Programme. (2005) (18)
- Transforming the global tuberculosis response through effective engagement of civil society organizations: the role of the World Health Organization. (2011) (18)
- Tuberculosis control is crucial to achieve the MDGs (2010) (18)
- Cardiopulmonary resuscitation in patients with the acquired immunodeficiency syndrome. A prospective study. (1988) (17)
- Children under 5 years are at risk for tuberculosis after occasional contact with highly contagious patients: outbreak from a smear-positive healthcare worker (2017) (17)
- Global burden of tuberculosis: past, present and future (2005) (17)
- Issues Facing TB Control (7) Multiple Drug-Resistant Tuberculosis (2000) (17)
- Northern Uganda (2002) (16)
- Trends in tuberculosis in the UK (2018) (16)
- Pneumocystis carinii in bone marrow. (1988) (16)
- Tuberculosis among asylum seekers in Milan, Italy: epidemiological analysis and evaluation of interventions (2019) (16)
- Association of tuberculosis risk with the degree of tuberculin reaction in HIV-infected patients. The Gruppo Italiano di Studio Tubercolosi e AIDS. (1997) (14)
- TB deaths rank alongside HIV deaths as top infectious killer. (2016) (14)
- Guidelines of tuberculosis preventive therapy for HIV-infected persons: a prospective, multicentre study. GISTA (Gruppo Italiano di Studio Tubercolosi e AIDS). (2001) (14)
- S. aureus nasal carriage among homosexual men with and without HIV infection. (1991) (13)
- Reply to 'Addressing smoking cessation in tuberculosis control'. (2007) (13)
- Aiming for zero tuberculosis transmission in low-burden countries. (2017) (13)
- Latent Tuberculosis Infection Treatment Completion while Shifting Prescription from Isoniazid-Only to Rifampicin-Containing Regimens: A Two-Decade Experience in Milan, Italy (2019) (13)
- Toward Tuberculosis Elimination in Low-Incidence Countries: Reflections From a Global Consultation (2014) (12)
- Molecular evidence for SARS-CoV-2 in samples collected from patients with morbilliform eruptions since late 2019 in Lombardy, northern Italy (2021) (12)
- Cost-effectiveness analysis of tuberculosis control policies in Ivanovo Oblast, Russian Federation. Ivanovo Tuberculosis Project Study Group. (1998) (12)
- A New World Health Era (2018) (12)
- Ending tuberculosis in India: A political challenge & an opportunity (2018) (12)
- European recommendations on surveillance of antituberculosis drug resistance. (2000) (12)
- Group G streptococcal meningitis and sepsis in a patient with AIDS. A method to biotype group G streptococcus. (1990) (11)
- PROCUREMENT OF SECOND-LINE ANTI-TUBERCULOSIS DRUGS FOR DOTS-PLUS PILOT PROJECTS (2000) (11)
- Migration: an opportunity for the improved management of tuberculosis worldwide (2012) (11)
- Intermittent co-trimoxazole prophylaxis against Pneumocystis carinii pneumonia (1990) (11)
- Global Tuberculosis Programme, World Health Organization, Geneva, (2016) (11)
- Pleural Pneumocystis carinii infection. (1991) (11)
- Rational use of anti-tuberculosis drugs in the EU: better patient care and less drug resistance (2012) (11)
- Perspective: Weigh all TB risks (2013) (11)
- Digital health to end tuberculosis in the Sustainable Development Goals era: achievements, evidence and future perspectives (2017) (10)
- Tuberculosis: still a social disease [Editorial]. (2011) (10)
- Tuberculosis research and development: seeding the future. (2018) (10)
- Risk of infection and estimated incidence of tuberculosis in northern Uganda. (1994) (9)
- Preventive therapy for tuberculosis in HIV-infected persons: analysis of policy options based on tuberculin status and CD4+ cell count. Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA). (1998) (9)
- Rebalancing the global battle against tuberculosis. (2014) (9)
- Targeting harmful use of alcohol for prevention and treatment of tuberculosis: a call for action (2017) (9)
- Tuberculosis care and control. (2006) (9)
- The neglected role of Faith-based Organizations in prevention and control of COVID-19 in Africa (2020) (9)
- Global Epidemiology of Pediatric Tuberculosis (2015) (9)
- From threat to reality: the real face of multidrug-resistant tuberculosis. (2008) (8)
- Precision medicine and public health interventions: tuberculosis as a model? (2019) (8)
- Evidence-based Definition for Extensively Drug-resistant Tuberculosis. (2021) (8)
- Tuberculosis and poverty: what is being done [Counterpoint]. (2011) (8)
- Global Burden of Tuberculosis Supplemental Appendixes (1999) (8)
- Tuberculosis: epidemiology (2009) (7)
- Impact of socio-economic factors on Tuberculosis treatment outcomes in north-eastern Uganda: a mixed methods study (2021) (7)
- Surveillance of tuberculosis in the WHO European Region 1995-1996. (1998) (7)
- Characteristics and Clinical Implications of Carbapenemase-Producing Klebsiella pneumoniae Colonization and Infection, Italy (2021) (7)
- Prospective multicentre study on the evaluation of antituberculosis treatment results in Italy: comparison of the culture- versus the smear-based methods. National AIPO Tuberculosis Study Group. (1999) (7)
- Harnessing the Power of Data to Guide Local Action and End Tuberculosis (2017) (7)
- Migrants' health: Building migrant-sensitive health systems (2019) (6)
- Drug-resistant tuberculosis: latest advances. (2013) (6)
- Engaging health-care workers to reduce tuberculosis transmission. (2016) (6)
- Quality tuberculosis care. All should adopt the new international standards for tuberculosis care. (2014) (6)
- Precision global health: a roadmap for augmented action (2020) (6)
- TB Elimination Requires Discovery and Development of Transformational Agents (2020) (6)
- Antituberculosis drug resistance: Is it worth measuring? (1996) (5)
- Antituberculosis drug resistance: is it worth measuring? The WHO/IUATLD Working Group on Antituberculosis Drug Resistance Surveillance. (1996) (5)
- The Internet of Things to come: digital technologies and the End TB Strategy (2016) (5)
- HERA: a new era for health emergency preparedness in Europe? (2021) (5)
- Trends of tuberculosis (TB) in eastern europe and the former USSR (1994) (5)
- Commemorating World TB Day 2020: “IT’S TIME” — It’s time to End the Global TB Epidemic (2020) (5)
- Linezolid for extensively drug-resistant tuberculosis. (2013) (5)
- The pandemic of HIV-associated tuberculosis. (1996) (5)
- Drug-resistant tuberculosis in AIDS. (1990) (5)
- The European Respiratory Journal targets tuberculosis (2010) (5)
- TB CONTROL: ACHIEVEMENTS, OBSTACLES AND THE ROLE OF VACCINES (2014) (5)
- The global plan to stop TB, 2006-2015: summary. (2006) (5)
- Tuberculosis—a World Health Organization Perspective (2011) (5)
- Hospital or home? Scripting a high point in the history of TB care and control (2012) (5)
- Rapid impact of effective chemotherapy on transmission of drug-resistant tuberculosis: pity the guinea pig. (2014) (4)
- Chapter 105 – The history of the DOTS strategy: Achievements and perspectives (2009) (4)
- Rebuttal: Evidence and uncertainties. (2002) (4)
- Improved bacteriological data are needed to give uniform reporting of tuberculosis in Europe (1998) (4)
- Erring on the side of action: time for HIV programmes to implement isoniazid preventive therapy. (2009) (4)
- A road map to control malaria, tuberculosis, and human immunodeficiency virus/AIDS. (2009) (4)
- Tuberculosis is a global health issue: challenges and need for new tools (2010) (4)
- Communicable Diseases Cluster Prevention and Control Department WHO Meeting to co-ordinate the DOTS-plus workplan on pilot projects for the management of multidrug resistant (MDR) tuberculosis (TB) (2000) (4)
- Latent tuberculosis screening and treatment among asylum seekers: a mixed-methods study (2020) (4)
- Variations in tuberculosis prevalence, Russian Federation: a multivariate approach (2019) (4)
- Migrant health and tuberculosis. (2017) (4)
- Epidemiology, Control and Treatment of Multidrug-Resistant Tuberculosis (2012) (4)
- Population surveillance and prevention strategies for tuberculosis (1997) (3)
- Waiting for the truth: is reluctance in accepting an early origin hypothesis for SARS-CoV-2 delaying our understanding of viral emergence? (2022) (3)
- Global ecological analysis of COVID-19 mortality and comparison between “the East” and “the West” (2022) (3)
- Machiavelli and the chief resident (1990) (3)
- Epidemiology of Tuberculosis (1997) (3)
- APPEARANCE OF CHLOROQUINE-RESISTANT FALCIPARUM MALARIA IN SWAZILAND (1987) (3)
- Towards optimization of surveillance resistance to antituberculosis drug resistance. (2000) (3)
- The principles of primary health care and social justice (2009) (3)
- No antimicrobial resistance research agenda without tuberculosis. (2020) (2)
- TB/HIV : a clinical manual for South East Asia / Anthony D. Harries and Dermot Maher; with contributions from Mario C. Raviglione ... [et al.] and a foreword by John Crofton (1997) (2)
- Risk of Exposure to HIV-Infected Body Fluids Among Medical Housestaff (1992) (2)
- Tuberculosis : The Essentials, Fourth Edition (2016) (2)
- Where is the ‘global’ in the European Union’s Health Research and Innovation Agenda? (2019) (2)
- Informed patient consent for defaulter tracing: should we obtain it? (2009) (2)
- Digital health technology for the end TB strategy: Developing priority products and making them work (2016) (2)
- DOTS and multidrug-resistant tuberculosis (2000) (2)
- Monitoring global health (2005) (2)
- Hurry up and wait? Accelerating access to the Three I's for HIV-TB. (2012) (2)
- Household tuberculosis interventions—how confident are we? (2013) (2)
- Political rationale, aims, and outcomes of health-related high-level meetings and special sessions at the UN General Assembly: A policy research observational study (2022) (2)
- Tuberculosis control: hard questions (2014) (2)
- Tuberculosis in the Western Pacific Region: Estimating the burden of disease and return on investment 2020–2030 in four countries (2020) (2)
- Tuberculosis and HIV infection (1993) (2)
- Antituberculosis therapy and current global guidelines (2011) (1)
- WHO’s Stop TB Strategy: Progress and Prospects (2009) (1)
- COVID-19 vaccines: evidence, challenges and the future (2021) (1)
- No accountability, no results-the difficult task of advocating for tuberculosis solutions. (2019) (1)
- Tuberculosis, Public Health Aspects (2017) (1)
- A postgraduate qualification in TB, message in a bottle. (2020) (1)
- Interferon beta in COVID-19: a landmark looming in the uncharted sea of COVID-19? (2020) (1)
- Cover Editorial- IJID World TB Day 2020 Theme Series. (2020) (1)
- Errata : new drugs for the treatment of tuberculosis : needs, challenges, promise, and prospects for the future (Journal of Infectious Deseases, vol. 205, p. S241-S249, 2012) (2012) (1)
- [182] Tuberculosis and Latent Tuberculosis Infection Screening Among Asylum Seekers in Milan, Italy (2019) (1)
- 058-PA12 Tuberculosis control in the caucasus: a priority for WHO (1995) (1)
- Controlling multidrug-resistant tuberculosis in India – Authors' reply (2007) (1)
- Joint WHO/ERS initiative on e-/m-Health for TB and tobacco control (2015) (1)
- Secular trends oftuberculosis inWestern Europe (1993) (1)
- Here is diabetes in The Lancet's tuberculosis Series! (2010) (1)
- Elective Courses in Global Surgery for Undergraduate Medical Students: A Narrative Review and a Proposal for European Universities (2022) (1)
- World Tuberculosis Day 2009: partnership for TB care. (2009) (1)
- Tuberculosis screening in outpatient healthcare workers: lessons from a high-income, low TB burden country. (2019) (1)
- Evaluation of the Global TB Drug Facility (2003) (1)
- A Multisectoral Approach to Tuberculosis Control and Elimination in the Era of the United Nations Sustainable Development Goals (2021) (1)
- Prevention and control of tuberculosis during air travel (2010) (1)
- Synergy between government and non-governmental organizations in health: WHO and the Union collaboration in tuberculosis control (2021) (1)
- Basic and Descriptive Epidemiology of Tuberculosis (2021) (1)
- No universal access to drug-resistant tuberculosis care without engaging all health care providers. (2020) (1)
- Moving the goalposts for tuberculosis targets in Africa (2013) (1)
- Tuberculosis and the strategy for the New Millennium: not simply “more of same” (2014) (0)
- 2 0 0 0 2 0 0 0 Series the Stop TB Ini (2000) (0)
- WHO's relationship with the Stop TB Partnership (2012) (0)
- International Standards for Tuberculosis Care: Finalmente il documento universale che aspettavamo (2006) (0)
- Cardiopulmonary Resuscitation in Patients with the Acquired Immunodeficiency Syndrome. A Prospective Study (1989) (0)
- Comprar Tuberculosis | Mario C. Raviglione | 9781420090215 | Informa Healthcare (2009) (0)
- Tuberculosis : a global emergency (2019) (0)
- Direct observation for tuberculosis treatment (2001) (0)
- 175-PA12 Incidence rates of tuberculosis in the native and immigrant population in Italy. The Varese study (1995) (0)
- TUBERCULOSIS TREATMENT IN DEVELOPING NATIONS. AUTHOR'S REPLIES (1995) (0)
- Preventive therapy of tuberculosis with rifapentine in immunocompetent and immunodeficient mice (1994) (0)
- Dr Mario Raviglione, director of the Stop TB Department World Health Organization. Interview by Christo Hall. (2012) (0)
- Hurry up and wait? Accelerating access to the Three I's for HIV-TB [Editorial]. (2012) (0)
- TB & HIV; a deadly duo (2011) (0)
- Monitoring global health [letter] (2005) (0)
- European recommendations on surveillance of antituberculosis drug resistance. (2000) (0)
- The History of the Wolfheze Workshops (2010) (0)
- The international approach to the control of tuberculosis (2013) (0)
- An African solution? (1999) (0)
- Chapter 106 – The WHO Stop TB Strategy for the coming decade (2009) (0)
- Tuberculosis and Other Mycobacterial Diseases (2015) (0)
- Towards optimisation of surveillance of resistance to antituberculosis drugs in Europe (2000) (0)
- Monitoring global health: WHO has the mandate and the expertise (2017) (0)
- Tuberculosis: current challenges and beyond (2023) (0)
- UHC—The critical platform towards a healthier and safer future in 2030 and beyond (2022) (0)
- 9.14 Tuberculosis (2009) (0)
- Global TB Control: Persisting Problem, Shifting Solutions (2009) (0)
- Extrapulmonary pneumocytosis in AIDS (1991) (0)
- Rational use of DST in programmes for control of drug-resistant TB (2008) (0)
- The future may not be so dark. (2001) (0)
- Challenge and Urgency to scale up tuberculosis care (2011) (0)
- Treatment of tuberculosis [editorial] (2003) (0)
- Cardiopulmonary Resuscitation in Patients With Acquired Immunodeficiency Syndrome-Reply (1989) (0)
- Tuberculosis: WHO-Recommended Strategies and Global Health Perspectives (2021) (0)
- Interview (2012) (0)
- S91 The global tuberculosis epidemic: burden, challenges and the international control strategy (2007) (0)
- High variability in tuberculosis treatment outcomes across 15 health facilities in a semi-urban area in central Ethiopia (2022) (0)
- Book Review (1996) (0)
- [World distribution of tuberculosis in 2002: short term perspectives]. (2003) (0)
- Tuberculosis care and control [editorial] (2006) (0)
- [Prevention of Pneumocystis carinii pneumonia with intermittent trimethoprim-sulfamethoxazole]. (1992) (0)
- Title Target regimen profiles for treatment of tuberculosis : a WHO document Permalink (2017) (0)
- Prediction of expected tuberculosis cases in Uganda (1994) (0)
- Extensively Drug-resistant Tuberculosis, Italy and Germany (2007) (0)
- Giving a voice to those who die young: the fatal impact of tuberculosis and HIV in South Africa. (2010) (0)
- Tuberculosis Treatment in Developing Nations-Reply (1995) (0)
- Tuberculosis and HIV infection [letter] (1993) (0)
- The One Hundred-Fold Difference in COVID-19 Mortality between the East and the West: An Ecological Analysis of Country Characteristics and Responses to the 2020 Pandemic (2021) (0)
- Harnessing the energy of the corporate sector to end TB: BE health (2020) (0)
- Tuberculosis and COVID-19 Comorbidity: A New Twenty-First-Century Cursed Duet (2021) (0)
This paper list is powered by the following services:
Other Resources About Mario Raviglione
What Schools Are Affiliated With Mario Raviglione?
Mario Raviglione is affiliated with the following schools: